Clinical trial
Gene Therapy for the Treatment of Fanconi's Anemia Type C
NCT00001399 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00001399 |
|---|---|
| Title | Gene Therapy for the Treatment of Fanconi's Anemia Type C |
| Official title | Retroviral Mediated Gene Transfer of the Fanconi Anemia Complementation Group C Gene to Hematopoietic Progenitors of Group C Patients |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Fanconi's Anemia, Pancytopenia |
| Intervention type | Drug |
| Interventions | Transduced CD34+ Cells |
| Enrollment | 9 |
| Start date | Dec 3, 1993 |
| Completion | Feb 11, 2009 |
| First posted | Nov 4, 1999 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: